Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Yogen Dalal
AddedFeb 13, 2024
UpdatedJun 28, 2026
Yogen Dalal

Yogen Dalal

Board Member, AudienceScience

CrunchbaseLinkedInThe Org

Yogen Dalal's Career

AudienceScience
AudienceScience

Bellevue, WA, US

Board Member· Board
Glooko
Glooko

Palo Alto, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Yogen Dalal's Career

AudienceScience
AudienceScience
Series B$111.5M1002010Bellevue, WA, US
Board Member· Board

Leadership at AudienceScience

Steve AdamsSteve AdamsBoard Member
Rob WardRob WardBoard Member
Geoffrey A MooreGeoffrey A MooreBoard Member
Bill EricsonBill EricsonBoard Member
Bill GossmanBill GossmanBoard Member
Usama FayyadUsama FayyadBoard Member
Glooko
Glooko
Series D$201M2822010Palo Alto, CA, US
Board Member· Board

Leadership at Glooko

Chamath PalihapitiyaChamath PalihapitiyaCo-Founder
Wende HuttonWende HuttonBoard Member
Sunny MadraSunny MadraCo-Founder
Charles BooradyCharles BooradyBoard Member
Alfonso ZuluetaAlfonso ZuluetaBoard Member
Russ JohannessonRuss JohannessonBoard Member

Similar to Glooko

GlumetricsGlumetricsIrvine, CA, USGlucose Monitors, Medical Devicesest. 2005GlumetricsIrvine, CA, US · est. 2005

GluMetrics Inc.: A US-based medical device company specializing in innovative glucose monitoring solutions.

Series A · $68.2M30
DexcomDexcomSan Diego, CA, USGlucose Monitors, Medical Devicesest. 1999DexcomSan Diego, CA, US · est. 1999

Dexcom, Inc.: A San Diego-based medical device company specializing in continuous glucose monitoring systems for diabetics.

Public · $1.4B7.6k
GlucoIQGlucoIQNew York City, NY, USData Platform, Wireless Glucometerest. 2015GlucoIQNew York City, NY, US · est. 2015

GlucoIQ: Real-time wireless glucometer data platform enhancing patient engagement and health outcomes.

Seed · $20k5
Integrity ApplicationsIntegrity ApplicationsAshkelon, Southern District, ILMedical Devicesest. 2010Integrity ApplicationsAshkelon, Southern District, IL · est. 2010

GlucoTrack, Inc.: Innovating non-invasive glucose monitoring devices for diabetes care in the US and Israel.

Public · $50.7M5

Yogen Dalal's Co-Investors

Betsy CohenBetsy CohenCo-invested · Resonance Pre-SeedJoshua BenaimJoshua BenaimCo-invested · Resonance Pre-SeedJoe KrausJoe KrausCo-invested · SeedJoi ItoJoi ItoCo-invested · SeedGarrett CampGarrett CampCo-invested · SeedMark PincusMark PincusCo-invested · SeedTim JurkaTim JurkaCo-invested · SeedAndy HertzfeldAndy HertzfeldCo-invested · Seed

Yogen Dalal's Similar Executives & Operators

WILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailJaeHong ChoiJaeHong ChoiBoard Member · KakaoKim Beom-sooKim Beom-sooCo-Founder · KakaoMason YeoMason YeoBoard Member · KakaoBrian KimBrian KimCo-Founder · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Yogen Dalal

Somshankar DasSomshankar DasCo-Founder · IonoAndy DerrickAndy DerrickCo-Founder · ArtSquareChristopher LuuChristopher LuuBoard Member · 3Pillar GlobalJohn BenderJohn BenderBoard Member · AsignioJamie HoldenJamie HoldenBoard Member · KazooChris ChanChris ChanCo-Founder · TrueFacet